Skip to main content
Equibles
ALZN logo

ALZN · Alzamend Neuro, Inc. · Webcasts, Transcripts & Audio

Track ALZN — free

Use ALZN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALZN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.12 -0.13 (-10.40%)
Rebalance outlook locked
Going-concern doubt — flagged Sep 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors create substantial doubt about our ability to continue as a going concern for at least one year after the date that our condensed financial statements are issued.”
View the 10-Q filed Sep 10, 2026
Market Cap
$5.69M
Shares
4.83M
Volume · Oct 22 15.29K Avg daily vol (3M) 80.15K

Alzamend Neuro, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Alzamend Neuro, Inc. (ALZN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Key facts CIK 1677077 CUSIP 02262M605 13F (30d) 2 filings 2 filers Visit website Investor relations